DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/7cb7pz/u_s) has announced the addition of the "U.S. Neuromodulation, Neurovascular, Neurosurgical and Monitoring Device Market (Executive Summary)" report to their offering.
Growth will be fueled by an aging baby boomer population, favorable reimbursement, increasing neurological procedure growth and extensive technological advancement, especially in the area of interventional neuroradiology and neuromodulation
The spinal cord and deep brain stimulator markets are poised to generate significant revenue growth as companies capitalize on favorable reimbursement and increasing adoption.
The shunting market in the U.S. is an established, mature market. However, shunting procedure volumes are experiencing moderate to high growth in the treatment of normal pressure hydrocephalus (NPH). NPH is characterized by normal hydrocephalus pressure; however, the gradual blockage of CSF drainage leads to an enlargement in the ventricles, leading to symptoms seen in hydrocephalus patients. Improved diagnosis is contributing to growth in shunting procedures for this segment.
While adoption rates of ICP monitoring remain high, companies must contend with less invasive monitoring regimens, which may prove as efficacious as current ICP devices.
Executive Summary Key Points
- U.S. Neuromodulation, Neurovascular, Neurosurgical and Monitoring Device Market
- Growth Trends by Segment
- Cerebrospinal Fluid Shunt Market
- Intracranial Pressure Monitoring Device Market
- Coil and Liquid Embolic Markets
- Neurovascular Catheter and Guidewire Markets
- Neurovascular Stent Market
- Neuromodulation Market
- Spinal Cord Stimulator Market
- Deep Brain Stimulator Market
- Neuroendoscope Market
- Aneurysm Clip Market
- Intrathecal Pump Market
- Boston Scientific
- Codman & Shurtleff
- Integra LifeSciences
- Mizuho America
- St. Jude Medical
For more information visit http://www.researchandmarkets.com/research/7cb7pz/u_s